Literature DB >> 17599055

The clock gene Per2 links the circadian system to the estrogen receptor.

S Gery1, R K Virk, K Chumakov, A Yu, H P Koeffler.   

Abstract

Circadian rhythms regulate diverse physiological processes including homeostatic functions of steroid hormones and their receptors. Estrogen receptor-alpha (ERalpha) is essential for normal mammary gland physiology and is a prognostic marker for the treatment of breast cancer. We report that Per2, a core clock gene, links the circadian cycle to the ERalpha signaling network. Binding of enhances ERalpha degradation, while suppression of Per2 levels leads to ERalpha stabilization. In turn, Per2 itself is estrogen inducible in these cells, suggesting a feedback mechanism to attenuate stimulation by estrogen. In addition, overexpression of Per2 in breast cancer cells leads to significant growth inhibition, loss of clonogenic ability and apoptosis. Taken together, these results further support a critical role for peripheral circadian regulation in tissue homeostasis and suggest a novel role for clock genes in estrogen receptor-positive breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599055     DOI: 10.1038/sj.onc.1210585

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  81 in total

Review 1.  Regulation of metabolism: the circadian clock dictates the time.

Authors:  Saurabh Sahar; Paolo Sassone-Corsi
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.

Authors:  Stefano Rossetti; Joseph Esposito; Francesca Corlazzoli; Alex Gregorski; Nicoletta Sacchi
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma.

Authors:  Nils H Thoennissen; Gabriela B Thoennissen; Sam Abbassi; Shayan Nabavi-Nouis; Tim Sauer; Ngan B Doan; Sigal Gery; Carsten Müller-Tidow; Jonathan W Said; H Phillip Koeffler
Journal:  Leuk Lymphoma       Date:  2012-02-21

Review 4.  Circadian rhythms and cancer.

Authors:  Sigal Gery; H Philip Koeffler
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

Review 5.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

6.  Estrogen directly modulates circadian rhythms of PER2 expression in the uterus.

Authors:  Takahiro J Nakamura; Michael T Sellix; Michael Menaker; Gene D Block
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-26       Impact factor: 4.310

7.  The role of circadian rhythm in breast cancer.

Authors:  Shujing Li; Xiang Ao; Huijian Wu
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

Review 8.  Decanalizing thinking on genetic canalization.

Authors:  Kerry Geiler-Samerotte; Federica M O Sartori; Mark L Siegal
Journal:  Semin Cell Dev Biol       Date:  2018-05-24       Impact factor: 7.727

9.  Per2 inhibits k562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction.

Authors:  Cheng-ming Sun; Shi-feng Huang; Jian-ming Zeng; Din-bing Liu; Qing Xiao; Wen-jun Tian; Xi-dan Zhu; Zong-gan Huang; Wen-li Feng
Journal:  Pathol Oncol Res       Date:  2009-12-03       Impact factor: 3.201

Review 10.  Clocks, metabolism, and the epigenome.

Authors:  Dan Feng; Mitchell A Lazar
Journal:  Mol Cell       Date:  2012-07-27       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.